265 related articles for article (PubMed ID: 18370196)
1. Delivery of tumor-antigen-encoding mRNA into dendritic cells for vaccination.
Michiels A; Tuyaerts S; Bonehill A; Heirman C; Corthals J; Thielemans K
Methods Mol Biol; 2008; 423():155-63. PubMed ID: 18370196
[TBL] [Abstract][Full Text] [Related]
2. Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients.
Bonehill A; Van Nuffel AM; Corthals J; Tuyaerts S; Heirman C; François V; Colau D; van der Bruggen P; Neyns B; Thielemans K
Clin Cancer Res; 2009 May; 15(10):3366-75. PubMed ID: 19417017
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of cancer with dendritic cells loaded with tumor antigens and activated through mRNA electroporation.
Van Nuffel AM; Corthals J; Neyns B; Heirman C; Thielemans K; Bonehill A
Methods Mol Biol; 2010; 629():405-52. PubMed ID: 20387165
[TBL] [Abstract][Full Text] [Related]
4. Induction of antigen-specific CD8+ cytotoxic T cells by dendritic cells co-electroporated with a dsRNA analogue and tumor antigen mRNA.
Michiels A; Breckpot K; Corthals J; Tuyaerts S; Bonehill A; Heirman C; Thielemans K; Aerts JL
Gene Ther; 2006 Jul; 13(13):1027-36. PubMed ID: 16511519
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell vaccine with mRNA targeted to the proteasome by polyubiquitination.
Hosoi A; Takeda Y; Sakuta K; Ueha S; Kurachi M; Kimura K; Maekawa R; Kakimi K
Biochem Biophys Res Commun; 2008 Jun; 371(2):242-6. PubMed ID: 18423376
[TBL] [Abstract][Full Text] [Related]
6. Preclinical full-scale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccination.
Kyte JA; Kvalheim G; Aamdal S; Saebøe-Larssen S; Gaudernack G
Cancer Gene Ther; 2005 Jun; 12(6):579-91. PubMed ID: 15818380
[TBL] [Abstract][Full Text] [Related]
7. Truncated TERT mRNA transfected dendritic cells evoke TERT specific antitumor response in vivo.
Qiu J; Lil GW; Sui YF; Sun YJ; Huang YY; Si SY; Ge W; Song HP
Hepatogastroenterology; 2007; 54(75):681-7. PubMed ID: 17591041
[TBL] [Abstract][Full Text] [Related]
8. Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA.
Kyte JA; Mu L; Aamdal S; Kvalheim G; Dueland S; Hauser M; Gullestad HP; Ryder T; Lislerud K; Hammerstad H; Gaudernack G
Cancer Gene Ther; 2006 Oct; 13(10):905-18. PubMed ID: 16710345
[TBL] [Abstract][Full Text] [Related]
9. IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro.
Vujanovic L; Ranieri E; Gambotto A; Olson WC; Kirkwood JM; Storkus WJ
Cancer Gene Ther; 2006 Aug; 13(8):798-805. PubMed ID: 16645618
[TBL] [Abstract][Full Text] [Related]
10. Cancer immunotherapy with mRNA-transfected dendritic cells.
Gilboa E; Vieweg J
Immunol Rev; 2004 Jun; 199():251-63. PubMed ID: 15233739
[TBL] [Abstract][Full Text] [Related]
11. Genetically engineered dendritic cell-based cancer vaccines (review).
Bubeník J
Int J Oncol; 2001 Mar; 18(3):475-8. PubMed ID: 11179474
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells.
Bontkes HJ; Kramer D; Ruizendaal JJ; Kueter EW; van Tendeloo VF; Meijer CJ; Hooijberg E
Gene Ther; 2007 Feb; 14(4):366-75. PubMed ID: 17036057
[TBL] [Abstract][Full Text] [Related]
13. Enhanced protein expression by internal ribosomal entry site-driven mRNA translation as a novel approach for in vitro loading of dendritic cells with antigens.
Tan X; Wan Y
Hum Immunol; 2008 Jan; 69(1):32-40. PubMed ID: 18295673
[TBL] [Abstract][Full Text] [Related]
14. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
[TBL] [Abstract][Full Text] [Related]
15. Induction of Influenza Matrix Protein 1 and MelanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cells.
Tuyaerts S; Michiels A; Corthals J; Bonehill A; Heirman C; de Greef C; Noppe SM; Thielemans K
Cancer Gene Ther; 2003 Sep; 10(9):696-706. PubMed ID: 12944989
[TBL] [Abstract][Full Text] [Related]
16. Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: implications for cancer immunotherapy protocols.
Dullaers M; Breckpot K; Van Meirvenne S; Bonehill A; Tuyaerts S; Michiels A; Straetman L; Heirman C; De Greef C; Van Der Bruggen P; Thielemans K
Mol Ther; 2004 Oct; 10(4):768-79. PubMed ID: 15451461
[TBL] [Abstract][Full Text] [Related]
17. Efficient genetic modification of murine dendritic cells by electroporation with mRNA.
Van Meirvenne S; Straetman L; Heirman C; Dullaers M; De Greef C; Van Tendeloo V; Thielemans K
Cancer Gene Ther; 2002 Sep; 9(9):787-97. PubMed ID: 12189529
[TBL] [Abstract][Full Text] [Related]
18. [Enhanced translational efficacy of internal ribosomal entry site-mediated mRNA in dendritic cells contributes to efficient induction of antitumor immunity].
Tan XH; Wan YH
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):399-403. PubMed ID: 17456382
[TBL] [Abstract][Full Text] [Related]
19. Generation of antigen-presenting cells using cultured dendritic cells and amplified autologous tumor mRNA.
Minami K; Yamaguchi Y; Ohshita A; Kawabuchi Y; Ohta K; Hihara J; Toge T
Oncology; 2005; 69(5):399-407. PubMed ID: 16319511
[TBL] [Abstract][Full Text] [Related]
20. Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines.
Michiels A; Tuyaerts S; Bonehill A; Corthals J; Breckpot K; Heirman C; Van Meirvenne S; Dullaers M; Allard S; Brasseur F; van der Bruggen P; Thielemans K
Gene Ther; 2005 May; 12(9):772-82. PubMed ID: 15750615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
